Economic and quality of life impact of dry eye symptoms in women with Sjögren's syndrome

Advances in Experimental Medicine and Biology

Volumn 506 B, Issue , 2002, Pages 1183-1188

  Sullivan, R M ^a   Cermak, J M ^a,b,c   Papas, A S ^d   Dana, M R ^a,b,c   Sullivan, D A ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIALLERGIC AGENT; ANTIDEPRESSANT AGENT; ARTIFICIAL TEAR; BROMHEXINE; CORTICOSTEROID; CYCLOSPORIN; DECONGESTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PILOCARPINE;

ADULT; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONSULTATION; CONTROLLED STUDY; DRY EYE; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; LIFESTYLE; MEDICAID; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; SELF CARE; SJOEGREN SYNDROME; TREATMENT OUTCOME;

EID: 0036927153     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0717-8_167     Document Type: Conference Paper

References (0)